Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 070803
Company: ABBOTT
Company: ABBOTT
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ENFLURANE | ENFLURANE | 99.9% | LIQUID;INHALATION | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/27/1987 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 07/08/1999 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 01/16/1997 | SUPPL-2 | Labeling |
Label is not available on this site. |